IP Library Granted Patent US 12,584,164
Granted Patent B2
US 12,584,164 · App. 17/612,037 · Granted Mar 24, 2026

System and method for detecting inhibition of a biological assay

Inventors: Wilfredo Dominguez-Nunez (Minneapolis, MN); Raj Rajagopal (Woodbury, MN); Nicholas A. Asendorf (St. Paul, MN); Saber Taghvaeeyan (Maple Grove, MN)
Assignee: NEOGEN FOOD SAFETY US HOLDCO CORPORATION
C12Q1/6848C12Q1/689G16B40/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,584,164
App. No.
17/612,037
Granted
Mar 24, 2026
Kind
B2
Abstract

In some examples, a system for detecting inhibition of a biological assay includes a detection device configured to amplify and detect a target nucleic acid. The detection device is configured to receive a sample comprising a matrix and a quantity of the target nucleic acid and to amplify the target nucleic acid within the sample over a nucleic acid amplification cycle. The detection device is configured to capture a data set including measurements of the nucleic acid collected during the amplification cycle. The system further includes a computing device configured to receive the data set and to apply a machine-learning system to the data set to detect inhibited biological assays that tested negative for the target nucleic acid due to matrix inhibition.

Claims (39)

1 . A system for detecting inhibition of a biological assay, comprising:

a detection device configured to amplify and detect a target nucleic acid associated with a target organism during the biological assay, the detection device comprising:

a reaction chamber configured to receive a sample comprising a matrix and a quantity of the target nucleic acid and to amplify the target nucleic acid within the sample over a nucleic acid amplification cycle;

a detector, the detector configured to capture, during the nucleic acid amplification cycle, measurements representative of a quantity of the target nucleic acid present in the sample and to store the measurements in a data set;

a machine learning system configured to receive the data set, wherein the machine-learning system includes processing circuitry trained to detect biological assays inhibited due to matrix inhibition;

wherein the machine-learning system is further trained to estimate a quantity of the target organism present in the sample based on measurements present in:

a first data subset, the first data subset including the measurements taken prior to a first point in time, the first point in time occurring prior to a time Tmax, wherein the time Tmax corresponds to a time in the nucleic acid amplification cycle when the measurements reach a maximum amplitude;

a second data subset, the second data subset including the measurements taken after the first point in time but before a second point in time in the nucleic acid amplification cycle, the second point in time occurring after Tmax;

a third data subset, the third data subset including the measurements taken after the second point in time in the nucleic acid amplification cycle;

wherein the nucleic acid cycle has a Tmax;

wherein a data set is comprised of the first data subset, the second data subset, and/or the third data subset;

wherein said data set is analyzed based on said trained machine learning system to estimate the quantity of the target organism in the matrix, and/or to indicate whether a threshold amount of the target organism is present; and

in the event that a test is a negative test, said machine learning system is configured to check if said negative test is a false negative.

2 . The system of claim 1 , wherein the detector measures at least one of bioluminescence, fluorescence, absorbance, transmittance, or reflectance.

3 . The system of claim 1 , wherein the detector is configured to detect the nucleic acid from at least one of live cells, injured cells, stressed cells, or viable but non-culturable cells.

4 . The system of claim 1 , wherein the reaction chamber is configured to perform an amplification technique comprising one or more of LAMP, PCR, nucleic acid sequence-based amplification, or transcription-mediated amplification.

5 . The system of claim 1 , wherein the sample is selected from one of a food, a feed, water or a raw material.

6 . The system of claim 1 , wherein the sample is an environmental sample from an environment in which at least one of a food, a feed, water or a raw material is harvested, processed, packaged, or used.

7 . The system of claim 1 , wherein the target organisms are microorganisms of one or more Salmonella species, one or more Listeria species, one or more Campylobacter species, one or more Cronobacter species, one or more E. coli strains, one or more Vibrio species, one or more Shigella species, one or more Legionella species, one or more B. cereus strains, or one or more S. aureus strains, one or more types of viruses, or one or more genetically modified organisms.

8 . The system of claim 1 , wherein the reaction chamber is further configured to amplify the target nucleic acid in the sample over a plurality of nucleic acid amplification cycles, and

wherein the detector is further configured to capture the measurements across the plurality of nucleic acid amplification cycles.

9 . The system of claim 1 , wherein the machine learning system is based on a regression model.

10 . The system of claim 1 , where the reaction chamber is further configured to receive a module, wherein the module includes:

a first plurality of reaction vessels, each vessel of the first plurality of reaction vessels containing a quantity of a lysis buffer solution; and

a second plurality of reaction vessels, each vessel of the second plurality of reaction vessels containing quantities of one or more reagents configured for use in a nucleic acid amplification reaction.

11 . The system of claim 1 , wherein said computing device stores the parameters of the trained machine learning system to one or more storage components of a system, wherein said storage components are chosen from a memory of a computing device, user device, and/or a memory of a computing device of access point.

12 . A non-transitory computer-readable medium storing instructions that, when executed by processing circuitry, cause the processing circuitry to:

establish a machine-learning system trained to detect matrix-inhibited biological assays;

receive a data set generated by amplifying and detecting a target nucleic acid associated with a target organism in a sample comprising a matrix and a quantity of the target nucleic acid over a nucleic acid amplification cycle, the data set including measurements representative of the quantity of the target nucleic acid present in the sample;

determine, by applying the machine-learning system to the data set, whether the data set is from a matrix-inhibited sample;

label the data set accordingly;

wherein the machine-learning system is further trained to estimate a quantity of the target organism present in the sample based on measurements present in:

a first data subset, the first data subset including the measurements taken prior to a first point in time, the first point in time occurring prior to a time Tmax, wherein the time Tmax corresponds to a time in the nucleic acid amplification cycle when the measurements reach a maximum amplitude;

a second data subset, the second data subset including the measurements taken after the first point in time but before a second point in time in the nucleic acid amplification cycle, the second point in time occurring after Tmax;

a third data subset, the third data subset including the measurements taken after the second point in time in the nucleic acid amplification cycle;

wherein the nucleic acid cycle has a Tmax;

wherein a data set is comprised of the first data subset, the second data subset, and/or the third data subset;

wherein said data set is analyzed based on said trained machine learning system to estimate the quantity of the target organism in the matrix, and/or to indicate whether a threshold amount of the target organism is present; and

in the event that a test is a negative test, said machine learning system is configured to check if said negative test is a false negative.

Assignments (4)
SECURITY INTEREST Recorded Sep 2, 2022
From: NEOGEN CORPORATION; NEOGEN FOOD SAFETY US HOLDCO CORPORATION
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 061372/0264 →
PATENT ASSIGNMENT AGREEMENT Recorded Sep 1, 2022
From: 3M INNOVATIVE PROPERTIES COMPANY
To: GARDEN US HOLDCO CORPORATION
Reel/Frame 061365/0688 →
CHANGE OF NAME Recorded Sep 1, 2022
From: GARDEN US HOLDCO CORPORATION
To: NEOGEN FOOD SAFETY US HOLDCO CORPORATION
Reel/Frame 061370/0437 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2021
From: DOMINGUEZ-NUNEZ, WILFREDO; RAJAGOPAL, RAJ; ASENDORF, NICHOLAS A.; TAGHVAEEYAN, SABER
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 058138/0338 →
Continuity (2)
Provisional Application 62850198 · May 20, 2019
Related Publication 20220220547A1 · Jul 14, 2022
References Cited (24)
US 6733645B1 · Chow · 2004 [cited by applicant]
US 20040197845A1 · Hassibi · 2004 [cited by applicant]
US 20070134652A1 · Slepnev · 2007 [cited by applicant]
US 20090123935A1 · Jahan · 2009 [cited by examiner]
US 20110008785A1 · Tan · 2011 [cited by applicant]
US 20170046480A1 · Almassian · 2017 [cited by examiner]
US 20210010076A1 · Delubac · 2021 [cited by examiner]
US 20210241857A1 · Fraley · 2021 [cited by examiner]
WO WO199102817 · 1991 [cited by applicant]
WO WO2004062338 · 2004 [cited by applicant]
WO WO2011161186 · 2011 [cited by applicant]
WO WO2018119443 · 2018 [cited by applicant]
WO WO2020047081 · 2020 [cited by applicant]
Bar, “Kinetic outlier detection(KOD) in real-time PCR”, Nucleic acids research, information retrieval Ltd., 2003, vol. 31, No. 17, pp. e105, 7 pages. [cited by applicant]
Dub, “A specific statistical model and algorithm related to the detection of mollicutes in contaminated biological samples by real-time transcription mediated amplification”, Microbiol Methods, 2012, vol. 88, No. 2, pp.… [cited by applicant]
Hoorfar, “Making Internal Amplification Control Mandatory for Diagnostic PCR”, Journal of Clinical Microbiology, vol. 41, No. 12, 2003, pp. 5835. [cited by applicant]
Hoorfar, “Practical Considerations in Design of Internal Amplification Controls for Diagnostic PCR Assays”, Journal of Clinical Microbiology, 2004, vol. 42, No. 5, pp. 1863-1868. [cited by applicant]
Hyeon, “Development of multiplex real-time PCR with internal amplification control for simultaneous detection of Salmonella and Cronobacter in powdered infant powder”, International Journal of Food Microbiology 2010, vo… [cited by applicant]
Nau, “Substrate-Selective Supramolecular Tandem Assays: Monitoring Enzyme Inhibition of Arginase and Diamine Oxidase by Fluorescent Dye Displacement from Calixarene and Cucurbituril Macrocycles”, J. Am. Chem. Soc., 2009… [cited by applicant]
Oikonomou, “Selective PCR: a novel internal amplification control strategy for enhanced sensitivity in [cited by applicant]
Tichopad, “Quality control for quantitative PCR based on amplification compatibility test”, Methods, Academics Press, 2010, vol. 50, No. 4, pp. 308-312. [cited by applicant]
Velez, “Massively parallel digital high resolution melt for rapid and absolutely quantitative sequence profiling”, Scietific reports, 2017, vol. 7, No. 1, pp. 01-14. [cited by applicant]
XP55715711. [cited by applicant]
International Search report for PCT International Application No. PCT/IB2020/054617 mailed on Jul. 24, 2020, 6 pages. [cited by applicant]